NASDAQ:ABMD

Abiomed, Inc Earning Date

USA |NASDAQ |USD

ABMD Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Oct 28, 2021 Sep 2021 $0.97 $1.10 $1.01
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Oct 28, 2021 Sep 2021 $247.66M $252.59M $209.76M

Abiomed, Inc's next earnings date is Thursday, Oct 28, 2021 for the fiscal quarter ending Sep 2021.

ABMD Earnings Date & History Chart

ABMD Earnings & Revenue Forecast

ABMD Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 8 $1.08 $0.85 $1.21
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Mar 2022 10 $4.38 $3.76 $4.80
Mar 2023 9 $5.33 $4.86 $5.93

ABMD Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 1 $1.09 $1.09 $1.15
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Mar 2022 0 / 1 $4.38 $4.38 $4.36
Mar 2023 0 / 1 $5.34 $5.38 $5.23

ABMD Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 8 $263.76M $258.60M $267.41M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Mar 2022 10 $1.04B $1.04B $1.05B
Mar 2023 10 $1.20B $1.15B $1.26B

ABMD Earnings Date & Revenue History

ABMD Earnings History

|
Show More
Show More

ABMD Revenue History

|
Show More
Show More

Abiomed, Inc Next Earnings Date & Report

ABMD Next Earnings Date & Report Preview: Sep 2021 (FQ)

ABMD's next earnings date is Thursday, Oct 28, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 8 analysts, the average EPS estimation for Abiomed, Inc's next quarterly earnings is $0.97, with a low EPS estimation of $0.77, and a high estimation of $1.21.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 1 downward. The EPS 1 month trend is $0.97, the last 2 month trend is $0.97, and the 3 month trend is $1.03.

Based on 8 analysts, the average revenue estimation is $247.66M, with a low revenue estimation of $241.40M, and a high estimation of $251.30M.

Abiomed, Inc Previous Earnings Dates & Reports

ABMD Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Abiomed, Inc's previous earnings date was Aug 4, 2021 for its fiscal quarter ended Jun 30, 2021.

ABMD's earnings per share (EPS) was $1.10, beating the consensus analysts forecast of $1.03 by 6.62%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by 2.80%, and higher than the same period a year before (Jun 2020) by 89.66%.

Revenues were $252.59M, better than the forecast of $252.59M by 0.00%, up by 4.70% from the previous quarter , and up by 53.22% from the same period last year.

The company reported a net income of $-26.52M.

Free cash flow for the quarter was $48.19M , compared to $60.37M last quarter and $21.71M a year before.

ABMD Previous Earnings Date & Report Recap: Mar 2021 (FY)

Abiomed, Inc's previous annual earnings date was Apr 29, 2021 for its fiscal year ended Mar 31, 2021.

ABMD's earnings per share (EPS) was $3.83, missing the consensus analysts forecast of $4.81 by -20.37% , and lower than the previous year's EPS (Mar 2020) by -6.95%.

Revenues were $847.52M, better than the forecast of $837.30M by 1.22%, and up by 0.79% from previous year's revenue.

The company reported a net income of $225.53M, 11.09% higher than the previous year.

Abiomed, Inc reported a free cash flow of $221.19M for its fiscal year, compared to $270.91M a year ago.